Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome

Acta Derm Venereol. 2012 Jul;92(4):393-4. doi: 10.2340/00015555-1307.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Interleukin-1beta / analysis*
  • Middle Aged
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Remission Induction
  • Schnitzler Syndrome / diagnosis
  • Schnitzler Syndrome / drug therapy*
  • Schnitzler Syndrome / immunology
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta
  • Receptors, Interleukin-1